Recombinant activated factor VII in cardiac surgery - First, do no harm

Journal of Cardiothoracic Surgery

Volumn 2, Issue 1, 2007, Pages

  Warren, Oliver J ^a   Darzi, Ara W ^a   Athanasiou, Thanos ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7A; HEMOSTATIC AGENT; RECOMBINANT FVIIA; RECOMBINANT PROTEIN; THROMBOPLASTIN; UNCLASSIFIED DRUG;

DRUG INTERACTION; HEART ASSIST DEVICE; HEART SURGERY; HUMAN; METHODOLOGY; NOTE; RISK FACTOR; THROMBOEMBOLISM;

CARDIAC SURGICAL PROCEDURES; DRUG INTERACTIONS; FACTOR VIIA; HEART-ASSIST DEVICES; HEMOSTATICS; HUMANS; RECOMBINANT PROTEINS; RISK FACTORS; THROMBOEMBOLISM; THROMBOPLASTIN;

EID: 37749042130     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-2-50     Document Type: Letter

References (22)

1. Heise D Braeuer A Quintel M Recombinant activated factor VII (Novo7) in patients with ventricular assist devices: Case report and review of the current literature Journal of Cardiothoracic Surgery 2007, 2:47. 10.1186/ 1749-8090-2-47 17963487
2. Khan MM Hattori T Niewiarowski S Edmunds LH Jr. Colman RW Truncated and microparticle-free soluble tissue factor bound to peripheral monocytes preferentially activate factor VII Thromb Haemost 2006, 95(3):462-468. 16525574
3. Diamant M Nieuwland R Pablo RF Sturk A Smit JW Radder JK Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus Circulation 2002, 106(19):2442-2447. 10.1161/ 01.CIR.0000036596.59665.C6 12417540
4. Giesen PL Rauch U Bohrmann B Kling D Roque M Fallon JT Badimon JJ Himber J Riederer MA Nemerson Y Blood-borne tissue factor: Another view of thrombosis Proc Natl Acad Sci U S A 1999, 96(5):2311-2315. 26780 10051638 10.1073/pnas.96.5.2311
5. Engelmann B Initiation of coagulation by tissue factor carriers in blood Blood Cells Mol Dis 2006, 36(2):188-190. 10.1016/j.bcmd.2005.12.020 16473535
6. Rauch U Nemerson Y Circulating tissue factor and thrombosis Curr Opin Hematol 2000, 7(5):273-277. 10.1097/00062752-200009000-00003 10961576
7. Nieuwland R Berckmans RJ Rotteveel-Eijkman RC Maquelin KN Roozendaal KJ Jansen PG ten Have K Eijsman L Hack CE Sturk A Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant Circulation 1997, 96(10):3534-3541. 9396452
8. Nijziel M van Oerle R van 't Veer C van Pampus E Lindhout T Hamulyak K Tissue factor activity in human monocytes is regulated by plasma: implications for the high and low responder phenomenon Br J Haematol 2001, 112(1):98-104. 10.1046/j.1365-2141.2001.02545.x 11167790
9. Maugeri N Brambilla M Camera M Carbone A Tremoli E Donati MB de Gaetano G Cerletti C Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation J Thromb Haemost 2006, 4(6):1323-1330. 10.1111/j.1538-7836.2006.01968.x 16706978
10. Hattori T Khan MM Colman RW Edmunds LH Jr. Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds J Am Coll Cardiol 2005, 46(4):707-713. 10.1016/ j.jacc.2005.05.040 16098440
11. Kato H Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: Basic and clinical aspects Arterioscler Thromb Vasc Biol 2002, 22(4):539-548. 10.1161/01.ATV.0000013904.40673.CC 11950688
12. Jude B Zawadzki C Susen S Corseaux D Relevance of tissue factor in cardiovascular disease Arch Mal Coeur Vaiss 2005, 98(6):667-671. 16007822
13. Bom VJ Bertina RM The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII Biochem J 1990, 265(2):327-336. 1136891 2302175
14. Monroe DM Hoffman M Oliver JA Roberts HR Platelet activity of high-dose factor VIIa is independent of tissue factor Br J Haematol 1997, 99(3):542-547. 10.1046/j.1365-2141.1997.4463256.x 9401063
15. Hoffman M Monroe DM Roberts HR Human monocytes support factor X activation by factor VIIa, independent of tissue factor: Implications for the therapeutic mechanism of high-dose factor VIIa in hemophilia Blood 1994, 83(1):38-42. 8274750
16. Levi M Peters M Buller HR Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic review Crit Care Med 2005, 33(4):883-890. 10.1097/01.CCM.0000159087.85970.38 15818119
17. O'Connell KA Wood JJ Wise RP Lozier JN Braun MM Thromboembolic adverse events after use of recombinant human coagulation factor VIIa Jama 2006, 295(3):293-298. 10.1001/jama.295.3.293 16418464
18. Warren O Mandal K Hadjianastassiou V Knowlton L Panesar S John K Darzi A Athanasiou T Recombinant activated factor VII in cardiac surgery: A systematic review Ann Thorac Surg 2007, 83(2):707-714. 10.1016/ j.athoracsur.2006.10.033 17258029
19. Levy JH Fingerhut A Brott T Langbakke IH Erhardtsen E Porte RJ Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: Review of safety profile Transfusion 2006, 46(6):919-933. 10.1111/ j.1537-2995.2006.00824.x 16734808
20. Ferraris VA Ferraris SP Saha SP Hessel EA 2nd Haan CK Royston BD Bridges CR Higgins RS Despotis G Brown JR Spiess BD Shore-Lesserson L Stafford-Smith M Mazer CD Bennett-Guerrero E Hill SE Body S Perioperative blood transfusion and blood conservation in cardiac surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline Ann Thorac Surg 2007, 83(5 Suppl):S27-86. 10.1016/j.athoracsur.2007.02.099 17462454
21. Shander A Goodnough LT Ratko T A. MK Cohn S Diringer M Edmunds H Lawson J MacLaren R Ness P Shere-Wolfe R Dubois R Consensus recommendations for the off-label use of recombinant human factor VIIa (NovoSeven) therapy Pharmacy & Therapeutics 2005, 30:644-658.
22. Roberts HR Monroe DM White GC The use of recombinant factor VIIa in the treatment of bleeding disorders Blood 2004, 104(13):3858-3864. 10.1182/ blood-2004-06-2223 15328151